The NMDA receptor, an important protein in the brain, is involved in physiological processes such as synaptic transmission and synaptic plasticity which may underlie learning and memory. Pathological changes involving the NMDA receptors probably contribute to the development of epilepsy, acute neuronal damage such as that resulting from a stroke, and chronic neuropathologies like those associated with Alzheimer's disease. There is considerable interest in the development of pharmacological agents active in NMDA receptors as new therapeutic agents.
This new edition provides a fully revised account of the NMDA receptor. Each chapter has been prepared by a leading expert in the field and has been fully updated to cover recent developments in the molecular biology and pharmacology of the NMDA receptor.
"synopsis" may belong to another edition of this title.
Graham L. Collingridge is at University of Birmingham. Jeffrey C. Watkins is at University of Bristol.
"Provides several chapters that deal with the clinical implications of the experimental findings presented. The discussion of the potential uses of these agents in human disease is complete and provides a starting point in understanding the rationale of their use in clinical trials."--The Annals of Pharmacotherapy
"About this title" may belong to another edition of this title.
Seller: Hard To Find Editions, Bristol, AVON, United Kingdom
Hardcover. Condition: Good. 2nd Edition. This book has been read. Spine to rear hardcover has slight damage. However all pages intact with no highlighting or writing contained within. The spine has tight binding and the book is generally in good condition. Fast dispatch within and from the UK. 100% money back guarantee. Seller Inventory # ABE-1676576257496
Quantity: 1 available